Cheung K, Au T, Li Y, Han Z, Zhang Z, Seto M
EClinicalMedicine. 2025; 80:103039.
PMID: 39885958
PMC: 11780714.
DOI: 10.1016/j.eclinm.2024.103039.
Khalil A, Sotiriadis A, Baschat A, Bhide A, Gratacos E, Hecher K
Ultrasound Obstet Gynecol. 2025; 65(2):253-276.
PMID: 39815396
PMC: 11788470.
DOI: 10.1002/uog.29166.
Gerli M, Cala G, Beesley M, Sina B, Tullie L, Sun K
Nat Med. 2024; 30(3):875-887.
PMID: 38438734
PMC: 10957479.
DOI: 10.1038/s41591-024-02807-z.
Spingler T, Sonek J, Hoopmann M, Prodan N, Jonaityte G, Elger T
Arch Gynecol Obstet. 2023; 310(2):749-755.
PMID: 38091054
PMC: 11258052.
DOI: 10.1007/s00404-023-07311-2.
Okoror C, Arora S
Eur J Obstet Gynecol Reprod Biol X. 2023; 19:100211.
PMID: 37456970
PMC: 10345242.
DOI: 10.1016/j.eurox.2023.100211.
Prenatal screening and diagnosis of genetic abnormalities: SEGO, SEQC, AEDP consensus recommendations.
Prieto B, Adiego B, Suela J, Martin I, Santacruz B, Garcia-Planells J
Adv Lab Med. 2023; 1(3):20200043.
PMID: 37361494
PMC: 10197315.
DOI: 10.1515/almed-2020-0043.
Experience in prenatal genetic testing and reproductive decision-making for monogenic disorders from a single tertiary care genetics clinic in a low-middle income country.
Hanif A, Akbar F, Kirmani S, Jaffarali A, Zainab G, Malik A
BMC Pregnancy Childbirth. 2023; 23(1):431.
PMID: 37301973
PMC: 10257259.
DOI: 10.1186/s12884-023-05698-z.
Do online decision aids reflect new prenatal screening and testing options? An environmental scan and content analysis.
Lu J, McKinn S, Freeman L, Turbitt E, Bonner C
PEC Innov. 2023; 1:100038.
PMID: 37213778
PMC: 10194264.
DOI: 10.1016/j.pecinn.2022.100038.
The association of prenatal amniotic sex hormones and digit ratio (2D:4D) in children aged 5 to 70 months: A longitudinal study.
Ernsten L, Korner L, Schaper M, Lawrenz J, Richards G, Heil M
PLoS One. 2023; 18(3):e0282253.
PMID: 36952430
PMC: 10035896.
DOI: 10.1371/journal.pone.0282253.
Personalized recurrence risk assessment following the birth of a child with a pathogenic de novo mutation.
Bernkopf M, Abdullah U, Bush S, Wood K, Ghaffari S, Giannoulatou E
Nat Commun. 2023; 14(1):853.
PMID: 36792598
PMC: 9932158.
DOI: 10.1038/s41467-023-36606-w.
Maternal metabolomic profiling and congenital heart disease risk in offspring: A systematic review of observational studies.
Mires S, Reddy S, Skerritt C, Caputo M, Eastwood K
Prenat Diagn. 2023; 43(5):647-660.
PMID: 36617630
PMC: 10946495.
DOI: 10.1002/pd.6301.
Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders.
Hanson B, Scotchman E, Chitty L, Chandler N
Clin Sci (Lond). 2022; 136(22):1615-1629.
PMID: 36383187
PMC: 9670272.
DOI: 10.1042/CS20210380.
Invasive Prenatal Diagnostic Testing for Aneuploidies in Singleton Pregnancies: A Comparative Review of Major Guidelines.
Giovannopoulou E, Tsakiridis I, Mamopoulos A, Kalogiannidis I, Papoulidis I, Athanasiadis A
Medicina (Kaunas). 2022; 58(10).
PMID: 36295632
PMC: 9609299.
DOI: 10.3390/medicina58101472.
Clinical Assessment of Fetal Well-Being and Fetal Safety Indicators.
David A, Spencer R
J Clin Pharmacol. 2022; 62 Suppl 1:S67-S78.
PMID: 36106777
PMC: 9544851.
DOI: 10.1002/jcph.2126.
Foetal loss after chorionic villus sampling and amniocentesis in twin pregnancies: A multicentre retrospective cohort study.
Navaratnam K, Khairudin D, Chilton R, Sharp A, Attilakos G, Stott D
Prenat Diagn. 2022; 42(12):1554-1561.
PMID: 36097373
PMC: 9828484.
DOI: 10.1002/pd.6237.
Antenatal diagnosis of chorioamnionitis: A review of the potential role of fetal and placental imaging.
Hall M, Hutter J, Suff N, Zampieri C, Tribe R, Shennan A
Prenat Diagn. 2022; 42(8):1049-1058.
PMID: 35670265
PMC: 9543023.
DOI: 10.1002/pd.6188.
Uptake of prenatal genetic diagnosis and termination of pregnancy by Omani Muslim families at risk of genetic disorders: experience over a 9-year period.
Bruwer Z, Al Ubaidani S, Al Kharusi K, Al Murshedi F, Al-Maawali A, Al Sayegh A
J Community Genet. 2022; 13(3):303-311.
PMID: 35179721
PMC: 8854480.
DOI: 10.1007/s12687-022-00584-1.
Prenatal Invasive Testing at a Tertiary Referral Center in India: A Report of 433 Cases Under a Single Operator.
Bansal V, Jhaveri R
J Obstet Gynaecol India. 2022; 72(1):47-58.
PMID: 35125738
PMC: 8804047.
DOI: 10.1007/s13224-021-01496-9.
Increased nuchal translucency before 11 weeks of gestation: Reason for referral?.
Lugthart M, Bet B, Elsman F, van de Kamp K, de Bakker B, Linskens I
Prenat Diagn. 2021; 41(13):1685-1693.
PMID: 34592002
PMC: 9293299.
DOI: 10.1002/pd.6054.
Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities.
Lee J, Kwon J, Na S, Choe S, Seol H, Kim M
J Korean Med Sci. 2021; 36(4):e26.
PMID: 33496085
PMC: 7834898.
DOI: 10.3346/jkms.2021.36.e26.
